The Punjab government has started monitoring the sale of dexamethasone injections and tablets to curb the profiteering and stockpiling of drugs after the Oxford University confirmed on Tuesday that its use is critical of the coronavirus it can be very helpful in saving lives.
Scientists believe that readily available and affordable medicine could be beneficial to a large number of patients with COVID-19 in poor countries.
However, doctors in Pakistan are already treating critically ill coronavirus patients with the drug. Prof. Dr. Irshad Hussain, former Head of Medicine at King Edward Medical University (KEMU) / Mayo Hospital, confirmed, 'We are already prescribing the dexamethasone, both in the public and private sector, to patients with coronavirus having infiltrated into their lungs,'
However, the study reinforces the treatment after a successful trial that concluded that there was a significant reduction in mortality in the critically ill Covid-19 patients.
Prof. Irshad Hussain said that the drug has improved the oxygen saturation of critically ill patients with COVID-19 and prevented them from being admitted to hospitals. 'When the body's immune system is too weak to fight the coronavirus, it suppresses the cytokine storm,' he added.
However, he said, the drug does not respond to some serious patients. 'Therefore, alternative drugs such as actimara (toclizomab) are being piloted,' he added.
Well-known pharmacist and drug lawyer Noor Mohammad Mehr said that successful testing of dexamethasone on coronavirus patients could lead to the well-being of critically ill patients in countries like Pakistan.
Dexamethasone, he says, is a type of corticosteroid drug used to reduce inflammation in rheumatoid arthritis and asthma, multiple skin diseases, severe allergies, chronic obstructive pulmonary disease, scratches, brain swelling, and other conditions. happens. Antibiotics in the eyes after eye pain.
In adrenocortical insufficiency, he says, it should be used in conjunction with a drug that has higher mineral corticoid effects, such as fludrocortisone. Premature labor, he said, could be used to improve outcomes in a child's health.
Noor Mehr said the drug, called dexamethasone, was readily available in the market under various brand names, with MRPs ranging from 45 to 300. 'It can be taken orally or as an intramuscular injection or intravenously,' he said, adding that the effects of dexamethasone are often seen within a day and last for about three days.
Meanwhile, regarding the recent advances in the treatment of COVID-I9 where Dexamethasone may be effective in the treatment of infectious disease, the Chief Drug Controller wrote a letter to the Drug Controller / Deputy Drug Controller / Drug Inspector, Punjab, which monitors and In the current situation, controlling the sale of the said drug was of utmost importance so that a significant amount of COVID-19 was available for the treatment of patients.
Thus, he directed the officials to monitor the distribution of medicines. The concerned drug inspector should obtain the current stock position from the injection and tablet distributors of the respective brands and report it to the Office of the Chief Drug Controller (CDC). In addition, all drug inspectors should ensure that the sale of the drug is strictly on the prescription of registered medical practitioners.
Drug inspectors are further directed to show the existing dexamethasone brands in the market along with their distribution setup and submit their reports to the CDC office by 12 noon on Wednesday (today).
The Punjab Government is on a trial visit of Actimara (Tocleozomb) on critically ill coronavirus patients to see its usefulness and further recommendations accordingly.
0 Comments